Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01753141 · ClinicalTrials.gov registry record · NA
Smoking Treatment and Anxiety Management Program
A NA study, sponsored by Florida State University.
- Completed
- Registry status
- NA
- Development phase
- 378
- Enrollment target
NCT01753141: Completed NA study, sponsored by Florida State University.
NCT01753141 is a NA study that has completed, run by Florida State University. The registered enrollment target is 378 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01753141, a NA study, has completed, sponsored by Florida State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 378 participants
- Enrollment target
Study Summary
The Smoking Treatment and Anxiety Management Program (STAMP) is a treatment program focused on helping people manage their anxiety while quitting smoking. The study involves coming in to our clinic for 4 treatment sessions, with follow-ups for up to 2 years (a week 1, week 2, month 1, month 3, month 6, year 1, and year 2 follow-up). Participants will be paid $142.50 for their full participation as well as receive 6 weeks of free nicotine replacement patches.
Primary Outcome
The ASI is a 16-item self-report measure that assesses the fear of consequences of bodily sensations associated with anxiety. Items are rated on a five-point Likert-type scale ranging from 0 (very little) to 4 (very much) and a total score is computed by summing all items. The ASI is hierarchical in structure with one higher order factor (AS) and three subfactors (physical, cognitive, and social concerns). The physical concerns subscale includes items related to the fear of consequences or prese
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy for smoking cessation
- BEHAVIORAL Cognitive Behavioral Therapy for smoking cessation and anxiety sensitivity reduction.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 378 participants |
| Start Date | 2008-01 |
| Est. Completion | 2013-08 |
| Phase | NA |
What the finished NCT01753141 record still lists
NCT01753141 is an interventional study that assigns participants to a tested intervention. The registered 378 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower).
The record links to 0 conditions, and to 2 interventions - of which Cognitive Behavioral Therapy for smoking cessation is the first listed.
NCT01753141 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01753141 about?
NCT01753141 is a clinical study titled "Smoking Treatment and Anxiety Management Program". The Smoking Treatment and Anxiety Management Program (STAMP) is a treatment program focused on helping people manage their anxiety while quitting smoking. The study involves coming in to our clinic for 4 treatment sessions, with follow-ups for up to 2 years (a week 1, week 2, month 1, month 3, month...
What is the current status of trial NCT01753141?
This trial is currently completed. It is a NA study. The enrollment target is 378 participants. The study started on 2008-01. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01753141?
The interventions under investigation include: Cognitive Behavioral Therapy for smoking cessation (BEHAVIORAL), Cognitive Behavioral Therapy for smoking cessation and anxiety sensitivity reduction. (BEHAVIORAL).
Who is sponsoring clinical trial NCT01753141?
This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01753141's enrollment target sits among peer trials
378 274th of 2000 higher than 1,727 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04254185 · 378 participants · NA
Clinical Trial for Surgery of the Ulnar Nerve (SUN) at the Elbow
- NCT06616584 · 378 participants · Phase 2
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- NCT07024784 · 377 participants · Phase 2
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
- NCT04560673 · 380 participants · Phase 2
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia